The Harvard NeuroDiscovery Center is a pioneering biomedical research group focused on ending suffering from neurodegenerative diseases. By drawing on the intellectual strength and proven capability of the Harvard medical community and colleagues throughout the world, the NeuroDiscovery Center has developed a unique approach to understanding and treating these devastating diseases.
* Alzheimer's, Parkinson's, multiple sclerosis, ALS (amyotrophic lateral sclerosis) and other degenerative diseases of the brain.
* Combining academic creativity with a business-like approach to ensure a focused and efficient effort to advance the search for cures.
* Accelerating the pace of progress, from scientific discoveries to meaningful patient treatments.
* Real collaboration across the Harvard Medical community, prominent research centers worldwide and the private sector.
* Applying discoveries about one neurodegenerative disease to better understand the others.
Maher, Nancy, MPH
Role: Senior Project Manager, Harvard NeuroDiscovery Center
The MGH Neurology Clinical Trials Unit, Massachusetts ADRC, and Harvard NeuroDiscovery Center joined forces to fund the best novel ideas for innovative pilot projects aimed at understanding and developing treatments for neurodegenerative diseases. Out of 44 applications received, 11 were selected for funding. Applications were judged on the basis of scientific merit, novelty and the value of the project in obtaining preliminary data that could lead to sponsored research (investigator-initiated R01 research grants, career development awards, industry or foundation support). Watch for the next RFA in the fall.